These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 3180904)

  • 21. Relationship between cefpirome clearance, serum creatinine, weight and age in patients treated for infection.
    Wilcox MH; Pithie A; Smith G; Moreland TA; Davey PG; Finch RG
    J Antimicrob Chemother; 1991 Aug; 28(2):291-9. PubMed ID: 1778859
    [TBL] [Abstract][Full Text] [Related]  

  • 22. NONMEM analysis in determining the tri-exponential disposition of cefotaxime: a method of evaluating serum and urinary phase I data.
    Weber W; Harnisch L; Zimmer M; Rokitta C; Mendes P
    Int J Clin Pharmacol Ther; 1995 Oct; 33(10):560-4. PubMed ID: 8574507
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multiple-dose pharmacokinetics of cefpirome in long-term hemodialysis with high-flux membranes.
    Thalhammer F; Schmaldienst S; Elmenyawi I; Atteneder M; Burgmann H; Hollenstein U; Georgopoulos A; Graninger W; Putz D; Rosenkranz AR; Mayer G; Hörl WH; Breyer S
    Clin Pharmacol Ther; 1996 Dec; 60(6):645-50. PubMed ID: 8988066
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cefepime versus cefpirome: the importance of creatinine clearance.
    Lipman J; Wallis SC; Boots RJ
    Anesth Analg; 2003 Oct; 97(4):1149-1154. PubMed ID: 14500173
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics of cefpirome in pediatric patients.
    Nahata MC; Barson WJ; Puri SK
    Antimicrob Agents Chemother; 1995 Oct; 39(10):2348-9. PubMed ID: 8619595
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Disposition kinetics and urinary excretion of cefpirome after intravenous injection in buffalo calves.
    Rajput N; Dumka VK; Sandhu HS
    J Vet Sci; 2007 Mar; 8(1):21-5. PubMed ID: 17322770
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Penetration of cefpirome into the anterior chamber of the human eye after intravenous application.
    Egger SF; Alzner E; Georgopoulos M; Elmenyawi I; Huber-Spitzy V; Georgopoulos A; Grabner G
    J Antimicrob Chemother; 2000 Feb; 45(2):213-6. PubMed ID: 10660503
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High extracellular levels of cefpirome in unaffected and infected lung tissue of patients.
    Lindenmann J; Kugler SA; Matzi V; Porubsky C; Maier A; Dittrich P; Graninger W; Smolle-Jüttner FM; Joukhadar C
    J Antimicrob Chemother; 2011 Jan; 66(1):160-4. PubMed ID: 21081546
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The pharmacokinetics, safety, and tolerance of cefepime administered as an intravenous bolus or as a rapid infusion.
    Garrelts JC; Wagner DJ
    Ann Pharmacother; 1999 Dec; 33(12):1258-61. PubMed ID: 10630824
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intraperitoneal penetration of cefpirome.
    Kavi J; Ashby JP; Wise R; Donovan IA
    Eur J Clin Microbiol Infect Dis; 1989 Jun; 8(6):556-8. PubMed ID: 2504599
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics and pharmacodynamics of cefpirome in subcutaneous adipose tissue of septic patients.
    Sauermann R; Delle-Karth G; Marsik C; Steiner I; Zeitlinger M; Mayer-Helm BX; Georgopoulos A; Müller M; Joukhadar C
    Antimicrob Agents Chemother; 2005 Feb; 49(2):650-5. PubMed ID: 15673747
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [In vivo pharmacokinetic of amikacin and its pharmacodynamic in combination with cefepime, cefpirome and meropenem in an in vitro/ex vivo micropig model].
    Elkhaïli H; Pompei D; Peter JD; Linger L; Salmon J; Levêque D; Niedergang S; Salmon Y; Thierry RC; Monteil H; Jehl F
    Pathol Biol (Paris); 1997 May; 45(5):347-56. PubMed ID: 9296083
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The pharmacokinetics of cefuroxime after intravenous injection.
    Gower PE; Dash CH
    Eur J Clin Pharmacol; 1977 Nov; 12(3):221-7. PubMed ID: 590309
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cerebrospinal fluid penetration of cefpirome in patients with non-inflamed meninges.
    Nix DE; Wilton JH; Velasquez N; Budny JL; Lassman HB; Mitchell P; Divan K; Schentag JJ
    J Antimicrob Chemother; 1992 Apr; 29 Suppl A():51-7. PubMed ID: 1601757
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics and tissue penetration of cefpirome, a new cephalosporin.
    Kavi J; Andrews JM; Ashby JP; Hillman G; Wise R
    J Antimicrob Chemother; 1988 Dec; 22(6):911-6. PubMed ID: 3243739
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phase I study of E1040, a new parenteral cephem antibiotic.
    Nakashima M; Uematsu T; Kanamara M; Ueno K; Setoyama T; Tomono Y; Ohno T; Okano K; Morishita N
    J Clin Pharmacol; 1989 Feb; 29(2):144-50. PubMed ID: 2715371
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics of cefpirome during the posttraumatic systemic inflammatory response syndrome.
    Jacolot A; Incagnoli P; Edouard AR; Tod M; Petitjean O; Samii K; Mimoz O
    Intensive Care Med; 1999 May; 25(5):486-91. PubMed ID: 10401943
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetic/pharmacodynamic serum and urine profile of cefditoren following single-dose and multiple twice- and thrice-daily regimens in healthy volunteers: a phase I study.
    Sádaba B; Azanza JR; Quetglas EG; Campanero MA; Honorato J; Coronel P; Gimeno M
    Rev Esp Quimioter; 2007 Mar; 20(1):51-60. PubMed ID: 17530036
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multiple-dose pharmacokinetics and tolerability of gemifloxacin administered orally to healthy volunteers.
    Allen A; Bygate E; Vousden M; Oliver S; Johnson M; Ward C; Cheon A; Choo YS; Kim I
    Antimicrob Agents Chemother; 2001 Feb; 45(2):540-5. PubMed ID: 11158752
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Determination of cefpirome (HR 810) in serum and urine.
    Uihlein M; Klesel N; Seeger K
    Infection; 1988; 16(2):135-40. PubMed ID: 3372025
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.